CRIS Current Research Information System

PANE, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.739
NA - Nord America 1.584
EU - Europa 1.294
Continente sconosciuto - Info sul continente non disponibili 85
AF - Africa 77
SA - Sud America 74
OC - Oceania 2
Totale 4.855
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.543
VN - Vietnam 646
GB - Regno Unito 444
SG - Singapore 397
CN - Cina 325
IT - Italia 201
SE - Svezia 166
HK - Hong Kong 132
DE - Germania 109
FR - Francia 67
IN - India 65
BR - Brasile 53
CH - Svizzera 49
IE - Irlanda 49
RU - Federazione Russa 47
BD - Bangladesh 42
NL - Olanda 39
CA - Canada 27
FI - Finlandia 26
JP - Giappone 24
JO - Giordania 22
TG - Togo 22
ZA - Sudafrica 22
BG - Bulgaria 21
EE - Estonia 21
KR - Corea 16
PL - Polonia 13
CI - Costa d'Avorio 11
UA - Ucraina 10
AR - Argentina 9
PH - Filippine 9
NG - Nigeria 8
TH - Thailandia 8
TR - Turchia 8
ID - Indonesia 7
MY - Malesia 7
GR - Grecia 6
AT - Austria 5
EC - Ecuador 5
IQ - Iraq 5
IR - Iran 5
MX - Messico 5
ES - Italia 4
UZ - Uzbekistan 4
BE - Belgio 3
CO - Colombia 3
JM - Giamaica 3
SA - Arabia Saudita 3
TN - Tunisia 3
TW - Taiwan 3
AU - Australia 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
GT - Guatemala 2
IS - Islanda 2
MA - Marocco 2
PA - Panama 2
PK - Pakistan 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
CL - Cile 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GI - Gibilterra 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
MW - Malawi 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SC - Seychelles 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.771
Salva come PNG Salva come JPEG
Città #
Southend 422
Singapore 281
Chandler 173
Ashburn 167
Ho Chi Minh City 164
Hong Kong 122
Hanoi 118
San Jose 109
Fairfield 100
Dong Ket 86
Beijing 64
Houston 56
Santa Clara 52
Woodbridge 51
Seattle 50
Bern 48
Dublin 47
Princeton 45
Los Angeles 38
Wilmington 37
New York 35
Boardman 29
Ann Arbor 28
Cambridge 27
Bologna 23
Nanjing 23
Amman 22
Lauterbourg 22
Lomé 22
Sofia 21
Tokyo 21
Hefei 20
Westminster 20
Dallas 19
Milan 19
Padova 19
Da Nang 18
Haiphong 17
Medford 17
Buffalo 16
Helsinki 16
Council Bluffs 13
Abidjan 11
Seoul 11
Shenyang 11
Thái Nguyên 11
Ha Long 10
São Paulo 10
Turin 10
Jinan 9
Quận Bình Thạnh 9
Toronto 9
Berlin 8
Biên Hòa 8
Can Tho 8
Chicago 8
Guangzhou 8
Hangzhou 8
Hebei 8
Saint Petersburg 8
San Diego 8
Warsaw 8
Florence 7
Las Vegas 7
Rome 7
Tianjin 7
Vũng Tàu 7
Changsha 6
Des Moines 6
Falkenstein 6
Frankfurt am Main 6
Hải Dương 6
London 6
Monte Vista 6
Orem 6
Redondo Beach 6
Torino 6
Abeokuta 5
Bắc Giang 5
Jakarta 5
Lappeenranta 5
Ninh Bình 5
Quận Tân Phú 5
Redwood City 5
Turku 5
Bangkok 4
Bremen 4
Bắc Ninh 4
Chengdu 4
Mexico City 4
Montreal 4
Munich 4
Nanchang 4
Phoenix 4
Phủ Lý 4
Shanghai 4
Tashkent 4
Tuy Hoa 4
Điện Bàn 4
Amsterdam 3
Totale 3.072
Salva come PNG Salva come JPEG
Nome #
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia 391
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 288
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia 241
The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) 223
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 207
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib 201
BCR-ABL1 transcript detection in patients with Philadelphia-positive Acute Lymphoblastic Leukemia (ALL) using a new and high sensitive nanofluidic method 200
The Bcr-Abl kinase promotes aberrant expression of spliced oncogenic Ikaros isoforms in Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with tyrosine kinase inhibitors 196
The 'Next-in-Cml' Study: A Prospective Multicenter Study of Deep Sequencing of the BCR-ABL1 Kinase Domain in Philadelphia Chromosome-Positive Patients with Non-Optimal Responses to Tyrosine Kinase Inhibitor Therapy 188
TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia 176
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients. 173
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report 171
An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease 167
Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia. 163
Innovative phase I-II study of concomitant and consecutive treatment with Dasatinib and MK-0457 in refractory Ph+ CML and ALL patients 157
Impact of calreticulin mutations on treatment and survival outcomes in myelofibrosis during ruxolitinib therapy 155
One-Step Quantitative Molecular Approach for Detection of BCR/ABL1 Rearrangement and for Monitoring of Minimal Residual Disease in CML Patients: An Inter Laboratory Study 155
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 155
Expression of different isoforms of the B-cell mutator activation-induced cytidine deaminase (AID) in BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) Patients 153
Evaluation of Cepheid Xpert® BCR-ABL Monitor Assay in Three Italian Reference Centers for Monitoring of BCR-ABL Transcript Levels in CML Patients 151
High-resolution genomic profiling of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) patients identified novel recurrent copy number variations involved in both pathogenesis and resistance to tyrosine kinase inhibitors 148
Genome wide analysis of Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) reveals a recurring deletion of VPREB1 gene which affects B-cell differentiation 144
High-resolution molecular allelokaryotyping identifies novel genomic alterations in acute promyelocytic leukemia (APL) 143
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 135
Molecular Characterization of PAX5 alterations in Adult BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) 116
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) 110
null 91
A Real‐Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B‐Cell Lymphoma. 54
A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib 3
Totale 4.855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.597
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022469 0 21 40 39 53 27 8 26 21 51 92 91
2022/2023602 48 93 19 77 37 47 19 29 120 7 47 59
2023/2024129 8 29 10 7 4 40 5 5 7 4 1 9
2024/2025584 34 59 50 38 102 25 50 26 5 56 18 121
2025/20261.760 265 223 90 73 173 66 128 59 363 147 118 55
2026/2027127 43 84 0 0 0 0 0 0 0 0 0 0
Totale 4.855